ID
16009
Description
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00153907
Link
https://clinicaltrials.gov/show/NCT00153907
Keywords
Versions (2)
- 5/2/16 5/2/16 -
- 6/26/16 6/26/16 -
Uploaded on
June 26, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00153907
Eligibility Breast Cancer NCT00153907
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
prior therapy with vinca-alkaloids
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0042672
- UMLS CUI [1,2]
- C0392920
Description
gastrointestinal disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0017178
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Description
serious comorbidities
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
prior bone marrow or stem cell transplant
Data type
boolean
Alias
- UMLS CUI [1]
- C1504389
Description
hypersensitivity to fluorouracil
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0016360
Similar models
Eligibility Breast Cancer NCT00153907
- StudyEvent: Eligibility
C0027627 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
C0016360 (UMLS CUI [1,2])